NEW YORK (GenomeWeb) – SGI-DNA, a subsidiary of Synthetic Genomics, announced today that it has signed a deal making VWR the exclusive North American and European distributor of its synthetic biology reagents and technologies.

Included in the deal are SGI-DNA's HiFi 1-Step, Ultra, and Site-Directed Mutagenesis kits for DNA construct assembly, all of which are based on the company's Gibson Assembly DNA cloning methodology.

Additional terms of the agreement were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.